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Abstract
Background: Post-Stroke Depression with or without Anxiety (PSDA) is a common disorder in the chronic phase of
stroke. Neuropsychiatric problems, such as PSDA, have a negative impact on social reintegration and quality of life.
Currently, there is no evidence-based treatment available for reducing PSDA symptoms. In the recent literature on
depression in the general population it has been shown that depression complaints can diminish by cognitive
behavioural therapy (CBT). In the current study, the effectiveness of augmented, activation-based and individually
tailored CBT on the reduction of depression and anxiety will be investigated in patients with PSDA. Additionally, the
effects on various secondary outcome measures, such as quality of life, goal attainment and societal participation
will be evaluated. This study is embedded in a consortium of 4 interrelated studies on quality of life after stroke
(Restore4Stroke).
Methods/design: A multi-centre, assessor-blind, randomized controlled trial is conducted. A sample of 106 PSDA
patients, as assessed with the Hospital Anxiety and Depression Scale (HADS depression subscale >7), will be
recruited and randomly allocated to either an experimental or a control group. The experimental intervention
consists of an augmented CBT intervention. The intervention is based on CBT principles of recognizing, registering,
and altering negative thoughts and cognitions so that mood, and emotional symptoms are improved. CBT is
augmented with direct in-vivo activation offered by occupational or movement therapists. Patients in the control
group will receive a computerized cognitive training intervention. Outcomes will be assessed at baseline,
immediately post intervention, and at 6 and 12 months follow up.
Discussion: This study is the first randomized clinical trial that evaluates the (maintenance of) effects of augmented
CBT on post-stroke depression with or without anxiety symptoms. Together with three other projects, the
Restore4Stroke PSDA trial will provide novel information about the (treatment of) emotional problems and quality
of life after stroke.
Trial registration: Trial registration number: Dutch Trial Register NTR2999
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Background
Stroke causes a high burden of disease to patients as
well as to their caregivers. One year after a stroke, 35%
of the patients are functionally dependent, indicating
that stroke is a leading cause of disability [1]. Half of all
patients has problems in returning to their pre-stroke
daily routines [2]. Particularly the ensuing psychosocial
problems of stroke survivors have a negative impact on
their quality of life [3]. Emotional adjustments are asso-
ciated with changes in coping strategies which are
related to quality of life [4,5]. Additionally, it has been
shown that caregivers experience substantial burden
from their partners’ emotional problems as well [6].
Cognitive and emotional complaints are found in many
patients in the chronic phase after stroke [7]. Within the
first three months, post-stroke depressive symptoms can
spontaneously resolve. If this does not occur, these
symptoms can take a chronic course [8]. In the chronic
phase (usually defined as> 6 months post stroke), the
most frequent emotional symptoms are depression (23-
25%) and anxiety (19-23%) [9-12]. Post-stroke depression
and anxiety often co-occur and interact, but may also be
present in isolation. Apparently the post-stroke preva-
lence of anxiety is almost as high as it is for depression;
hence, it is surprising that the literature largely focuses
on post-stroke depression (PSD) [9-12]. Stressing the
impact and co-occurrence of anxiety on patients with
stroke, in the present study, we introduce the new con-
cept of ‘Post-Stroke Depression with or without Anxiety’
(PSDA).
Currently, we are not aware of any treatment studies
on post stroke anxiety. Studies on the treatment of PSD
have generally focused on pharmacological interventions
[13,14], whereas psychological interventions for PSD
have hardly been investigated [15]. Several researchers
have investigated the possibility of preventing depression
after stroke [16-19]. Different interventions were evalu-
ated, such as meditation, breathing exercises and visual-
isation (i.e., encouraging a new way of thinking about
disability) [16] and visits by specialist outreach nurses
providing information, advice and support [17]. In the
intervention studies, a small but statistically significant
reduction in psychological distress was reported on a
variety of health-related questionnaires. All intervention
studies were based on contact with multiple disciplines
providing information and support, yet no specific psy-
chological therapies were administered.
Nevertheless, there are indications that the treatment
of depressive symptoms using cognitive behavioural
therapy (CBT) is effective in other chronic illnesses such
as cancer and diabetes [20,21]. Hence, psychological
interventions seem promising in terms of effectiveness,
while they have fewer side effects than medication.
Moreover, as CBT is aimed at changing irrational
cognitions and negative thoughts, it is considered to
have a stronger effect on preventing relapse of symp-
toms than pharmacotherapy [5,16,20,22,23]. In one of
the studies that dealt with treatment of PSD, Lincoln
and colleagues, applied a treatment protocol in which
identifying and challenging negative thoughts as well as
planning of joyful activities was discussed with the
patients. The authors found, however, inconclusive
results with respect to the effectiveness of such a psy-
chological intervention [24,25]. CBT requires effort
during treatment sessions and often comes with a sub-
stantial amount of homework. The inconclusive results
could be due to the inclusion criteria that did not take
into account cognitive deficits and impaired awareness
after stroke. These factors are associated with poorer re-
habilitation outcomes [26] and are, therefore, deemed
essential when applying CBT. Next to discussing activa-
tion with the patients, no further steps, such as stimulat-
ing an active life style or giving practical suggestions and
encouragements directed at joyful activities, were taken
by Lincoln and colleagues [25]. Including such an extra
step in an intervention could possibly catalyse general-
isation of the content of the therapy to daily-life func-
tioning [15]. Furthermore, in a study with brain-injured
patients, a combination of CBT and individual cognitive
remediation seemed to diminish psychological distress
(e.g., depression, anxiety, coping) and improve attention
and cognitive functions. Nevertheless, which of the two
therapy ingredients was (most) effective could not be
determined [27]. Implementation of CBT should take
into account cognitive impairments as well as emotional
barriers and awareness. To stimulate treatment general-
isation, the use of behavioural exercises that have to be
executed in daily life situations is recommended [15].
Taken together, the scientific literature shows inconsist-
ent results on the effectiveness of treatment programs for
PSD. Despite a lack of clear evidence, there is sufficient
reason to believe that CBT offered by a trained psycholo-
gist can be effective in PSDA when adapted and tailored
to the specific needs of patients with stroke, as discussed
above [15]. Combining the results of earlier research on
treatment and prevention of post-stroke depression and
according to the recommendations expressed in these
studies [7], an augmented psychological approach to CBT
will be tested in the present study using a Randomised
Controlled Trial (RCT) design. An equally intensive con-
trol intervention (i.e., computerized cognitive training)
was selected with the prospect of improving intervention-
related goals (e.g., attention, memory, executive function-
ing) and attaining previously reported high patient satis-
faction [28].
The present study is a multi-centre randomized con-
trolled trial (RCT). The primary objective is to evaluate
the direct and long-term intervention effects on PSDA
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symptoms as assessed with the Hospital Anxiety and De-
pression Scale (HADS). It is hypothesised that patients
treated with augmented CBT, tailored to their needs, will
show a larger decrease in HADS scores than those re-
ceiving computerized cognitive training. The secondary
objectives are:
– to evaluate the effects on societal participation,
quality of life, goal attainment and coping strategies.
It is hypothesised that the augmented CBT will lead
to better outcomes in all these domains.
– to assess the level of burden of the patients’
caregivers. It is expected that the augmented CBT
will be more beneficial with respect to alleviating the
perceived burden (emotional as well as practical) of
caregivers.
– to evaluate the relationship between treatment
participation of the patients in CBT on the one
hand and treatment outcomes on the other hand.
The present study is part of a comprehensive rehabilita-
tion research program, Restore4Stroke, in the Netherlands
(www.restore4stroke.nl) comprising four interrelated stud-
ies. Restore4stroke aims to monitor, predict and improve
the quality of life of patients and their caregivers. Besides
the present RCT, three other studies are conducted: a lon-
gitudinal cohort study [29], an RCT aimed at evaluating
the effect of a self-management group therapy, and an
economical evaluation study [30]. The design of the other
studies will be published separately.
Methods
Study population
We intend to include 106 participants who experience
depressed mood with or without symptoms of anxiety after
stroke. When physicians, therapists or psychologists in the
Netherlands notice such complaints during the rehabilita-
tion process or thereafter, patients can be referred to vari-
ous rehabilitation centres offering the experimental and
control interventions distributed throughout the country.
Participants may also be referred by other healthcare pro-
fessionals or come on their own initiative based on ‘hear
say’. They will be eligible if they have sustained any type of
stroke in the past, if complaints developed after the stroke
and if their depression sub-score on the Hospital Anxiety
and Depression Scale (HADS) is above seven. Other inclu-
sion criteria are: (1) being more than three months post
stroke; (2) being 18 years or older; (3) having sufficient
communication skills (MMSE> 27, communication-related
NIHSS items); and (4) mastering the Dutch language. Ex-
clusion criteria are: (1) pre-morbid disability as assessed
with the Barthel Index (score< 19/20); (2) stay in an in-
patient setting; (3) co-morbidity that might affect outcome
(e.g., cancer or major psychiatric illnesses for which
psychological treatment is given at the moment of inclu-
sion); (4) a major depression diagnosis requiring medica-
tion; and (5) a pre-morbid major depression diagnosis, or
having received psychiatric care for depression.
Procedure
Participants will be screened, enrolled and subsequently
treated in several rehabilitation centres or rehabilitation
departments of hospitals in the Netherlands. They will
be recruited over a period of one year. Each centre is
expected to enrol at least 10 patients. The physicians of
the affiliated centres are provided with information
about the inclusion and exclusion criteria to perform a
first test of eligibility (HADS assessment). When indivi-
duals are considered to be candidates for the study, they
will be informed about the Restore4Stroke PSDA trial by
written correspondence and will be asked for permission
to be contacted by the primary investigator (JK). In the
case of a positive reply, the primary investigator will
make an individual appointment to confirm the inclu-
sion and exclusion criteria, to obtain oral and written
informed consent, and to perform the baseline assess-
ment (T0).
Participants will be randomly allocated to an experi-
mental group receiving augmented CBT or to a control
group receiving computerized cognitive training. All out-
come measures will be collected at baseline (T0), after
4 months (post treatment) (T1), and at 6 (T3) and
12 months (T4) follow up (see Figure 1). All assessments
will take place in the (patients’ nearest) participating
centres. From T1 assessments will be performed by re-
search assistants who are not involved in the delivery of
the interventions and who will be blind to the type of
intervention in individual participants. Prior to each as-
sessment, the assessor will explicitly ask the participant
not to reveal or discuss the content of his/her interven-
tion. Successfulness of assessor blinding will be tested by
the primary investigator at the end of each individual
intervention period using a short self-constructed ques-
tionnaire. During the intervention it is required that any
antidepressant medication intake remains stable. Yet,
when changes in medication occur these will be regis-
tered. This procedure was approved by the Committee
on research involving Human Subjects, Nijmegen, The
Netherlands, and all local participating centres.
Randomization
Stratified block randomization (block size n = 4) will take
place by a computer in each participating rehabilitation
centre separately. Participants will be stratified according
to their anxiety level (cut-off: HADS subscale anxiety
score ≤7 vs. > 7). In this way, all blocks will assumedly
consist of an equal number of participants with and
without anxiety complaints and each participating centre
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will provide both interventions in approximately an
equal number of participants.
Interventions
Augmented cognitive behavioural therapy
Subjects in the experimental group will be treated with
an augmented CBT protocol using ‘CRASS’ communica-
tion techniques [31]. The ‘CRASS’ techniques entail
Concrete, Repetitive, Accessible, Structured and Specific
communicative principles. Therapists will use motiv-
ational interviewing and interpersonal therapy techni-
ques. Patients will be taught to recognize, register, and
alter negative thoughts, cognitions and concurrent feel-
ings. To encourage daily life integration of the CBT, con-
tent sheets will be provided and related homework will
be given each session (i.e., one or two assignments per
session). The intervention is individually administered
and tailored according to specific subjects-own activity-
related goals. The treatment program consists of 10–12
sessions with an experienced health-care psychologist
and is augmented with three (or four; depending on
HADS anxiety scores) sessions of occupational therapy
(OT) or movement therapy (MT). These latter sessions
will be provided concurrently with the psychological ses-
sions and serve as a facilitator for reaching the pre-set
goals in daily life. Therapy goals will be set in terms of
increased participation in meaningful or joyful activities
using Activity Card Sorting (ACS) [32]. This tool is
incorporated to overcome problems with goal-setting
because of the passive state PSDA patients can be in.
With the ACS, patients can objectify their goals with the
help of pictures/photos that represent elderly participat-
ing in various activities. In this way, patients are given
concrete and accessible incentives to define their own
personal goals more easily. The OT/MT will help to ini-
tiate and guide patients to execute goal-related activities.
If patients’ HADS anxiety sub-score is >7, the protocol
will be expanded with an additional (fourth) OT/MT
session. Therapists will be informed about the HADS
anxiety sub-scores of the patient. The additional session
entails relaxation techniques as provided by the Dutch
Heart Foundation. The OT/MT can refer to the
Pre-selection of subjects in
rehabilitation centres or rehabilitation
departments of hospitals
Check for inclusion Exclusion of subjects
Baseline Measurement (T0)
Randomisation
Augmented CBT intervention Control intervention
(13-16 sessions, 4 months) (13-16 sessions, 4 months)
Post treatment
Measurement
T1
(4 months after T0)
Follow up
Measurement 1
T2
(10 months after T0)
Follow up
Measurement 2
T3
(16 months after T0)
Figure 1 Flow chart of trial design.
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relaxation techniques if patients report experienced anx-
iety during execution of their activities [33]. Next to
that, psychologists will address anxiety-related thoughts,
cognitions and concurrent feelings when executing CBT.
The protocol framework is set out in five successive
phases (see Table 1). The therapist will start with building
rapport creating a safe atmosphere. Psycho-education about
current mood states will guide and prepare patients for the
next phase: Goal setting. Subsequently, CBT will be exe-
cuted using explanatory schemes about negative and posi-
tive cognitions [34]. Themes of the CBT range within
patients-own goals and concurrent mood states. From this
stage the OT/MT will actively work with patients on their
treatment goals as well. CBT succeeds with continuation of
learned techniques and concludes with building a relapse
plan for future challenging situations.
All treatment sessions are supervised by certified health-
care psychologists who have sufficient experience with
treatment of depression as well as with stroke rehabilita-
tion. The psychologist will supervise the OT/MT and will
determine the sequence of the treatment sessions according
to the individual needs and capacities of the subjects. The
program is executed within a four-month time span, with a
minimum of 13 and a maximum of 16 sessions. Each ses-
sion will take two 20–25 minute-blocks divided by a 10–15
minute break. Treatment will be given at the most nearby
participating centre.
CogniPlus; computerized cognitive training
Subjects in the control group will be given a computer-
ized cognitive training program (CogniPlus). The
amount of training sessions will be equal to that of the
experimental group (i.e., 13–16 sessions). The control
intervention is individual and patient-tailored as well.
Participating centres will be provided with software and
a dongle with sufficient training hours. With headphones
and coloured patches attached to two keys on the key-
board, a desktop can be set up for CogniPlus execution.
Patients register on the system and for each session,
content and results of the training will be saved. The
program is an impairment-oriented intervention which
suits the stroke population. In specific self-determined
cognitive domains (i.e., attention, memory, executive
functioning, and visual attention) patients will be execut-
ing computer tasks on performance-own related levels.
A research or psychological assistant will be present dur-
ing the training sessions for support or to answer any
questions about the intervention. This person will, how-
ever, not engage in conversations with the patients about
topics other than the cognitive training. To assess deteri-
oration of mood, Visual Analogue Scales (VAS) will be
filled out by the participant after each session. The as-
sistant will monitor VAS scores and, when substantial
deterioration occurs, will notify the researcher and the
psychologist of the department.
Outcome assessment
Patients
Primary and secondary outcome measures are listed in
Table 2. The HADS is a depression and anxiety ques-
tionnaire developed for use in patients with somatic co-
morbidity such as stroke. We will assess domain-specific
as well as health-related quality of life. The primary out-
come measure is the depression subscale of the HADS
[35,36]. Health-related quality of life will be assessed in
general (EQ6D) [37], and stroke specific (SSQoL) [38].
Domain-specific quality of life is represented by
Table 1 Content of successive phases of the augmented
Cognitive Behavioural Therapy
Phase Content
1. Introduction Building rapport; discussing grief; psycho-education
about the relationship between mood and behaviour.
2. Goal setting Active goal setting with OT/MT.
3. CBT principles Recognising and registration of ‘hidden cognitions’.
4. CBT Challenging and altering ‘negative cognitions’.
5. Relapse
prevention
Building a relapse-prevention plan with
taught techniques.
Table 2 Outcome measures
Tests
Primary outcome
measure
Depression and
Anxiety
Hospital Anxiety and Depression Scale (HADS)
Secondary outcome
measures
Quality of Life
General Stroke Specific quality of Life (SSQoL-12)
EuroQuality of Life (EQ6D)
Domain specific User-P
Life Satisfaction questions
Post-stroke
depression
Post Stroke Depression Rating Scale (PSDRS)
Goal attainment Goal Attainment Scale (GAS)
Participation in
therapy
Pittsburgh Rehabilitation
Participation Scale (PRPS)
Coping strategy Utrecht Proactive Coping
Competence scale (UPCC)
Caregiver outcome
measures
Domain specific
quality of life
Hospital Anxiety and Depression Scale (HADS)
Subjective strain Caregiver Strain Index (CSI)
Emotional burden Involvement Evaluation Questionnaire (IEQ)
Kootker et al. BMC Neurology 2012, 12:51 Page 5 of 8
http://www.biomedcentral.com/1471-2377/12/51
participation assessment (USER-P) [39], Emotional func-
tioning (HADS), and subjective well-being (life satisfac-
tion questionnaires).
Next to these quality of life related assessments, a
semi-structured questionnaire specifically regarding
post-stroke depression will be used. The Post Stroke De-
pression Rating Scale (PSDRS) will accompany HADS
results emphasizing the phenomenological aspects of
post-stroke depression [40]. This scale comprises a
characterization of all depressive post stroke symptoms
(e.g., psychological, physical and vegetative aspects).
CBT is aimed at different aspects of coping such as
regulating emotional reactions and reassuring thoughts
(emotion-focused coping), changing stressful situation
and learning new skills (problem-focused coping) [41].
Consequently, we will assess coping using the Utrecht
Proactive Coping Competence scale (UPCC) [42]. Goal
setting will be performed with the therapist, and Goal
Attainment Scaling (GAS) will be carried out by the pri-
mary investigator (JK) [43]. Treatment participation will
be scored by the therapist per session. The Pittsburgh
Rehabilitation Participation Scale (PRPS) is a short
quantitative measure that is easy to administer [26]. The
PRPS will be completed in each session and can provide:
1) direct feedback on individual treatment participation
for the therapist, 2) direct feedback on treatment partici-
pation per session in general. If we come across trends
in reported participation, the protocol could be adjusted.
Caregivers
In addition to patient-related outcomes we will also as-
sess caregivers’ emotional and practical burden with the
HADS, the Involvement Evaluation Questionnaire (IEQ)
[44] and the Caregiver Strain Index (CSI) [6,45,46].
Statistical analysis
Statistical analysis will be performed using PASW 18.
Baseline characteristics will be presented using descrip-
tive statistics. Differences between groups at baseline will
be tested using chi-square and t-tests, depending on the
type of variable. General linear model (GLM) analysis
will be used to investigate the main effects of Time and
Group (experimental vs. control) and the Time x Group
interaction. Because it is hypothesized that augmented
CBT causes a greater effect on the HADS than cognitive
training and that this effect will last at least 6 months
after cessation of the therapy, the primary endpoint will
be at 6 months post treatment (T2). Data analysis will
be performed by an independent statistician who will be
blinded for group intervention. Data will be analysed
according the intention-to-treat principle. Alpha will be
set at 0.05.
Power
With a minimally detectable effect size of 0.6 SD on the
HADS, α= .05 and β= .80, minimally 45 participants in
each group are required. With an expected drop-out rate
of 15%, 106 participants will need to be recruited.
Discussion
Currently, no multi-centre RCT has been conducted that
has evaluated the effectiveness of an (augmented) CBT
intervention on post-stroke depression with or without
anxiety [47]. Reduction of PSDA could positively influ-
ence psychosocial functioning, rehabilitation outcome
and concurrently improve different domains of quality
of life. An innovative aspect of the current study is that
the CBT intervention takes into account recommenda-
tions by Broomfield and colleagues for the design of a
post-stroke CBT intervention [15]. Specifically, the pro-
posed CBT is augmented with occupational therapy or
movement therapy to facilitate change of behaviour in
real life by promoting and encouraging meaningful or
pleasurable activities. This augmentation may, however,
be a challenging factor in some individuals with lack of
initiative. These individuals may find it difficult to cope
with the amount of homework. Striving to overcome this
problem, only therapists with sufficient experience with
the stroke population will deliver the intervention, and
treatment participation will be monitored. Next to that,
the protocol continually emphasizes CRASS communi-
cation principles, and the ACS is offered as a tool to
provide input for conversation about joyful activities.
Another innovation in the present study is that depres-
sive symptoms are used for inclusion of subjects, but
that symptoms of anxiety are not considered a reason
for exclusion. In contrast, anxiety complaints will be
incorporated as a target for the proposed cognitive be-
havioural therapy.
An important methodological aspect of the present
study is that subjects from different parts of the Nether-
lands are included, which will enable us to control for
possible cultural differences between subgroups. An-
other methodological strength is that the augmented
CBT is compared to an ‘active’ intervention (and not to
‘usual care’) to control for Hawthorne effects. Lastly, a
parallel economic evaluation study within the Restore4S-
troke program will shed light on the cost-effectiveness of
the proposed intervention [30].
Taken together, the Restore4Stroke PSDA trial is an es-
sential part of the Restore4Stroke program that focuses
on the effectiveness of an augmented and individually tai-
lored CBT protocol for treating post-stroke depression
with or without anxiety. The Restore4Stroke program
will: provide longitudinal information about the course
of quality of life of patients and caregivers and the
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influence of personal factors on quality of life, evaluate
two interventions designed for stroke patients, and last
but not least will evaluate the economical effectiveness of
both trials.
Current study status
The Restore4Stroke PSDA trial has started recruitment
from the beginning of 2012.
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